TY  - JOUR
AU  - Roda Navarro, Pedro
AU  - Blanco, Belén
AU  - Ramírez-Fernández, Ángel
AU  - Aguilar-Sopeña, Óscar
AU  - Díez-Alonso, Laura
AU  - Segura-Tudela, Alejandro
AU  - Erce-Llamazares, Ainhoa
AU  - Rubio-Pérez, Laura
AU  - Jiménez Reinoso, Anaïs
AU  - Domínguez-Alonso, Carmen
AU  - Morales, Pablo
AU  - Paz Artal, Estela Natividad
AU  - Álvarez-Vallina, Luis
PY  - 2022
DO  - 10.1158/2326-6066.CIR-21-0853
SN  - 2326-6074
UR  - https://hdl.handle.net/20.500.14352/120088
T2  - Cancer Immunology Research
AB  - Chimeric antigen receptor (CAR)-modified T cells have revolutionized the treatment of CD19-positive hematologic malignancies. Although anti-CD19 CAR-engineered autologous T cells can induce remission in patients with B-cell acute lymphoblastic...
LA  - eng
M2  - 498
PB  - American Association for Cancer Research
TI  - Overcoming CAR-Mediated CD19 Downmodulation and Leukemia Relapse with T Lymphocytes Secreting Anti-CD19 T-cell Engagers.
TY  - journal article
VL  - 10
ER  -